Register entry

Guangdong Longfu Medicine Co Ltd

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Guangdong Longfu Medicine Co., Ltd.Registrant: Guangdong Longfu Medicine Co LtdNo.13 Simiao Road, South China Modem Chinese Medicine City, Nanlang Town, Zhongshan, Guangdong 528451, China (CHN)Analytical testing, Active ingredient (API) manufacture3016884736543118859
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
-TIRZEPATIDEpowder85781-001BULK INGREDIENT
Neighbours

Registered in the same town

3
Compare

Comparable companies in China

Enquiry

Common questions

Is Guangdong Longfu Medicine Co Ltd FDA approved?
Guangdong Longfu Medicine Co Ltd holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Guangdong Longfu Medicine Co Ltd's drugs manufactured?
The FDA register lists Zhongshan. Registered operations: analytical testing, active ingredient (API) manufacture.
What drugs does Guangdong Longfu Medicine Co Ltd make?
1 product is listed under Guangdong Longfu Medicine Co Ltd in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.